Investor presentation
Logotype for IDEX Corporation

IDEX (IEX) Investor presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for IDEX Corporation

Investor presentation summary

5 Mar, 2026

Strategic positioning and business model

  • Focuses on mission-critical engineered products, targeting higher-growth, specialized markets with proprietary technologies across diverse sectors.

  • Operates with an 8020 model emphasizing simplification, agility, and autonomy, supporting global brands in over 100 countries.

  • Maintains an asset-light manufacturing approach, leveraging proprietary and co-developed technologies for high-margin, specialized applications.

  • Continuously evolves its portfolio toward markets with secular growth trends, supported by disciplined capital allocation and M&A activity.

  • Prioritizes organic growth, strategic acquisitions, and double-digit EPS growth over the long term.

Segment performance and market focus

  • Health & Science Technologies led 2024 sales (39%), followed by Fluid & Metering Technologies (38%) and Fire & Safety/Diversified Products (23%).

  • Health & Science Technologies targets life sciences, semiconductors, and analytical instruments, with a 5% CAGR and 31% EBITDA margin in 2024.

  • Fluid & Metering Technologies serves industrial, water, energy, and agriculture markets, achieving a 7% CAGR and 33% EBITDA margin in 2024.

  • Fire & Safety/Diversified Products focuses on fire suppression, rescue tools, and dispensing, with a 5% CAGR and 29% EBITDA margin in 2024.

  • Strategic acquisitions in data centers, semiconductors, water, and defense enhance capabilities and market reach.

Financial performance and capital allocation

  • 2024 revenue reached $3.3B, with adjusted EBITDA of $874M and free cash flow of $603M.

  • Achieved 5.6% five-year revenue CAGR and 6.3% five-year adjusted EPS CAGR, despite recent market contractions in life sciences and semiconductors.

  • Maintains a gross leverage ratio below 2.0x, with a track record of rapid deleveraging post-acquisitions.

  • Targets 100%+ free cash flow conversion and consistent dividend payouts (30–35% of adjusted net income).

  • Increased share repurchase authorization to $1 billion as of September 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more